Please Note: This trial is no longer enrolling new participants
A Phase II Study of GT103 in Combination with Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer
| Protocol No. | CTO-HCRN-LUN21-497 | Scope | National |
|---|---|---|---|
| Principal Investigator | Greg Durm | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
